Skip to main content
SpringerLink
Log in

Effects of HMG CoA Reductase Inhibitors on Warfarin Binding

  • Short Communication
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Ahmad S. Lovastatin warfarin interaction. Archives of Internal Medicine 150: 2407, 1990

    Article  PubMed  CAS  Google Scholar 

  • Brers O, Jacobsen S. pH lability in serum during equilibrium dialysis. British Journal of Clinical Pharmacology 20: 85–88, 1985

    Article  Google Scholar 

  • East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA. Rhab-domyolysis in patients receiving lovastatin after cardiac transplantation. New England Journal of Medicine 318: 47–48, 1988

    Article  PubMed  CAS  Google Scholar 

  • Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. New England Journal of Medicine 319: 24–32, 1988

    Article  PubMed  CAS  Google Scholar 

  • LaRosa JC. Pravastatin: a new hydrophilic HMG-CoA-reductase inhibitor. In LaRosa (Ed.) New advances in the control of lipid metabolism: focus on pravastatin. Royal Society of Medicine Services International Congress and Symposium Series No. 162, 39–43, 1989

    Google Scholar 

  • McTavish D, Sorkin EM. Pravastatin: a review of its pharmacological properties and therapeutic potential in hyperchol-esterolaemia. Drugs 42 (1): 65–89, 1991

    Article  PubMed  CAS  Google Scholar 

  • O’Connor P, Feely J, Shepherd J. Lipid lowering drugs. British Medical Journal 300: 667–672, 1990

    Article  PubMed  Google Scholar 

  • Pan HY, Triscari J, de Vault AR, Smith SA, Wang-Iverson D, et al. Pharmacokinetic interaction between propranolol and the HMG-Co A Reductase inhibitors pravastatin and lovastatin. British Journal of Clinical Pharmacology 31: 665–670, 1991

    Article  PubMed  CAS  Google Scholar 

  • Todd PA, Goa KL. Simvastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs 40 (4): 583–607, 1990

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, Trinity College Medical School, St James’s Hospital, Dublin 8, Ireland

    John Feely & Patricia O’Connor

Authors
  1. John Feely
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feely, J., O’Connor, P. Effects of HMG CoA Reductase Inhibitors on Warfarin Binding. Drug Invest. 3, 315–316 (1991). https://doi.org/10.1007/BF03259744

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259744

Keywords

Search

Navigation